Evidence map›Paper›PMID 22476904›Full record

ArticleMolecular and cellular biochemistry2012

Sin3 interacts with Foxk1 and regulates myogenic progenitors.

Xiaozhong Shi, Daniel J Garry

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Foxk1 regulates cancer progression.Annals of translational medicine · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Zebrafish sin3b mutants are viable but have size, skeletal, and locomotor defects.Developmental dynamics : an official publication of the American Association of Anatomists · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Xiaozhong ShiLillehei Heart Institute, University of Minnesota-Twin Cities, 4-108 NHH, 312 Church St SE, Minneapolis, MN 55455, USA.
Daniel J Garry
University of Minnesota · US

Funding

Transcriptional Regulation of Myogenic Stem CellsR01AR055906 · NIAMS · UNIVERSITY OF MINNESOTA · PI GARRY, DANIEL J. · 2009 to 2013
$1.6M
NIAMS NIH HHS R01 AR055906
6 · The paper itself

Abstract

We have previously reported Foxk1 as an important transcription factor in the myogenic progenitors. SWI-independent-3 (Sin3) has been identified as a Foxk1 binding candidate using a yeast two-hybrid screen. In the present study, we have identified the Foxk1 N-terminal (1-40) region as the Sin3 interacting domain (SID), and the PAH2 of Sin3 as the Foxk1 binding domain utilizing yeast two-hybrid and GST pull-down assays. Further studies revealed that knockdown of Sin3a or Sin3b results in cell cycle arrest and upregulation of cell cycle inhibitor genes. In summary, our present studies have shown that Foxk1 interacts with Sin3 through the SID and that Sin3 has an important role in the regulation of cell cycle kinetics of the MPC population. The results of these studies continue to define and assemble the networks that regulate the MPCs and muscle regeneration.

Indexed as

AnimalsCell Cycle CheckpointsCell LineForkhead Transcription FactorsGene Expression ProfilingGene Knockdown TechniquesMicePeptide FragmentsProtein BindingProtein Interaction Domains and MotifsRepressor ProteinsRNA InterferenceSatellite Cells, Skeletal MuscleSin3 Histone Deacetylase and Corepressor ComplexTwo-Hybrid System TechniquesForkhead Transcription FactorsFoxk1 protein, mousePeptide FragmentsRepressor ProteinsSIN3A transcription factorSin3b protein, mouseSin3 Histone Deacetylase and Corepressor Complex

Identifiers

PMID22476904
PMCPMC4494651
OpenAlexW1966258042

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.